Status:

ACTIVE_NOT_RECRUITING

Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction

Lead Sponsor:

Brigham and Women's Hospital

Conditions:

Diabetes Mellitus, Type 2

HFpEF - Heart Failure With Preserved Ejection Fraction

Eligibility:

All Genders

18+ years

Brief Summary

Investigators are building an empirical evidence base for real-world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clin...

Detailed Description

This is a non-randomized, non-interventional study that is part of the Randomized Controlled Trials Duplicated Using Prospective Longitudinal Insurance Claims: Applying Techniques of Epidemiology (RCT...

Eligibility Criteria

Inclusion

  • Eligible cohort entry dates:
  • Optum: Study period between May 13, 2022 to November 30, 2024. Marketscan: Study period between May 13, 2022 to December 31, 2023.
  • Heart failure
  • BMI \> 27.0 kg/m2
  • History of type 2 diabetes mellitus
  • LVEF ≥ 45%
  • ≥ 18 years old, male or female sex

Exclusion

  • Prior treatment with any GLP-1-RA
  • History of type 1 diabetes mellitus
  • End-stage renal disease or chronic or intermittent haemodialysis or peritoneal dialysis
  • History of bariatric surgery
  • History of nursing home admission
  • Pregnant female or breastfeeding
  • Uncontrolled and potentially unstable diabetic retinopathy or maculopathy
  • Treatment with continuous subcutaneous insulin infusion
  • Multiple endocrine neoplasia type 2 or medullary thyroid carcinoma
  • Have a history of an active or untreated malignancy or are in remission from a clinically significant malignancy (other than basal- or squamous-cell skin cancer, in situ carcinoma of the cervix, or in situ prostate cancer) for less than 5 years

Key Trial Info

Start Date :

January 14 2025

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2025

Estimated Enrollment :

28118 Patients enrolled

Trial Details

Trial ID

NCT06914141

Start Date

January 14 2025

End Date

May 1 2025

Last Update

May 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02120